Selective inhibitors of viral functions. /

Por Carter, William A.
Publicado em [197

Interferon: Evidence for Subunit Structure

Por Carter, William A.
Publicado em 1970

Responses of the Murine Myeloid Colony-Forming Cell to Ansamycin Antibiotics

Por Horoszewicz, Julius S., Carter, William A.
Publicado em 1974

The quest for effective Ebola treatment: Ebola VP35 is an evidence-based target for dsRNA drugs

Por Mitchell, William M, Carter, William A
Publicado em 2014

Differential Susceptibility of Spleen Focus-Forming Virus and Murine Leukemia Viruses to Ansamycin Antibiotics

Por Horoszewicz, Julius S., Leong, Susan S., Carter, William A.
Publicado em 1977

Activity of Pure Streptovaricins and Fractionated Streptovaricin Complex Against Friend Virus

Por Horoszewicz, Julius S., Rinehart, Kenneth L., Leong, Susan S., Carter, William A.
Publicado em 1975

Antivirion Effects of Streptovaricin Complex Against Friend Virus

Por Horoszewicz, Julius S., Leong, Susan S., Byrd, Daniel M., Carter, William A.
Publicado em 1974

Differential Production of Interferon and Refractoriness Inducing Principle in L Cells

Por Chadha, Kailash C., Davey, Mary W., Byrd, Daniel M., Carter, William A.
Publicado em 1974

Comparative Production of Interferon by Human Fetal, Neonatal, and Maternal Cells

Por Carter, William A., Hande, Kenneth R., Essien, Boniface, Prochownik, Edward, Kaback, Michael M.
Publicado em 1971

A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

Por Strayer, David R., Carter, William A., Stouch, Bruce C., Stevens, Staci R., Bateman, Lucinda, Cimoch, Paul J., Lapp, Charles W., Peterson, Daniel L., Mitchell, William M.
Publicado em 2012